M&A - COLUMN GROUP III GP, LP

Form Type: SCHEDULE 13D/A

Filing Date: 2025-03-28

Corporate Action: Acquisition

Type: Update

Accession Number: 000095017025047114

Filing Summary: This Schedule 13D/A Amendment No. 4 is filed to disclose the purchases made by The Column Group III entities (TCG III LP, TCG III-A LP, TCG Opportunity III LP, and their general partners) of securities of Surrozen, Inc. as part of a two-tranche private placement agreement. The first tranche closed on March 26, 2025, involving the sale of 6,586,415 Units consisting of shares of common stock, pre-funded warrants, and Series E common warrants. The purchase price for the units was disclosed, with the share unit priced at $11.60. Additionally, operational details about the exercise price and the future milestones related to the second tranche are outlined, emphasizing the agreements in place including the right of the investors to purchase additional units under certain conditions tied to FDA clearance. This filing updates prior Schedule 13D submissions and maintains provisions about potential future share acquisitions or investments.

Document Link: View Document